세계의 장 건강 및 마이크로바이옴 보충제 시장 예측 : 제품 유형별, 성분별, 제제별, 유통 채널별, 용도별, 최종사용자별, 지역별 분석(-2032년)

According to Stratistics MRC, the Global Gut Health and Microbiome Supplement Market is accounted for $14.4 billion in 2025 and is expected to reach $26.1 billion by 2032 growing at a CAGR of 8.8% during the forecast period. Gut health and microbiome market focuses on probiotics, prebiotics, synbiotics, postbiotics, and tailored formulations aimed at supporting digestive health, immune function, and overall wellbeing via the gut microbiome. Growth is driven by expanding scientific evidence linking microbiome balance to health outcomes, rising preventive healthcare interest, and consumer demand for personalized nutrition. Advances in strain-specific research, delivery systems, and clinical validation enhance credibility.

According to a 2022 survey by the International Food Information Council (IFIC), one in four Americans considered gut health to be the most important aspect of their overall health, indicating high consumer awareness and demand for related products.

Market Dynamics:

Driver:

Growing demand for natural and plant-based supplements

The market is significantly propelled by a pronounced consumer pivot towards natural and plant-based wellness solutions. Modern consumers are increasingly wary of synthetic ingredients, seeking cleaner labels and products derived from recognizable sources. This trend is amplified by a growing body of research validating the efficacy of botanicals and natural strains of probiotics and prebiotics. Consequently, manufacturers are heavily investing in developing supplements from non-GMO, organic, and sustainable plant sources, directly aligning with this health-conscious consumer ethos and driving market expansion through targeted product innovation and marketing.

Restraint:

High cost of advanced supplement formulations

A primary factor limiting broader market penetration is the elevated price point of advanced microbiome supplements. These products often incorporate clinically studied, patented bacterial strains, sophisticated delivery systems like delayed-release capsules, and rigorous third-party testing for potency and purity. The associated research, development, and quality assurance costs are substantial and are passed on to the consumer. This creates a significant price barrier for a large segment of potential buyers, particularly in price-sensitive emerging markets, thereby restricting the overall market growth.

Opportunity:

Integration of supplements with functional foods and beverages

The fortification of products like probiotic juices, prebiotic snack bars, and fermented drinks offers a convenient and discrete consumption method, appealing to those who dislike swallowing pills. This strategy effectively expands the market reach beyond traditional supplement users to a broader health-aware demographic. Moreover, it encourages daily adherence and allows for continuous microbiome support, presenting a significant opportunity for cross-industry collaboration between supplement manufacturers and food and beverage companies.

Threat:

Potential side effects and adverse reactions

The market faces a persistent threat from the potential for side effects, such as initial bloating, gas, or more serious adverse reactions in immunocompromised individuals. These incidents, when they occur, can lead to negative consumer reviews, product returns, and in severe cases, legal challenges or regulatory scrutiny. Such events can rapidly erode consumer trust in a brand or even the broader supplement category. Maintaining transparent labeling, clear dosage instructions, and investing in consumer education is crucial to mitigate this threat and uphold the market's credibility.

Covid-19 Impact:

The pandemic served as a catalyst for the gut health supplement market, as consumers became intensely focused on bolstering their innate immunity. Widespread research linking a healthy gut microbiome to robust immune function drove a surge in demand for probiotics and prebiotics. However, this growth was tempered by initial disruptions in the global supply chain and raw material sourcing, leading to temporary shortages and production delays. The market ultimately adapted, with the pandemic leaving a lasting legacy of heightened consumer awareness about proactive health management.

The probiotics segment is expected to be the largest during the forecast period

The probiotics segment is projected to account for the largest market share, a dominance rooted in strong scientific validation and deep-rooted consumer familiarity. Decades of clinical research have conclusively established the benefits of specific probiotic strains for digestive wellness, immune support, and even mental health, giving consumers and healthcare professionals high confidence in these products. Furthermore, probiotics represent the most mature and well-defined category within the microbiome space, with an extensive range of over-the-counter options available. This established market presence and proven efficacy make probiotics the default and most trusted choice for a majority of consumers seeking gut health solutions.

The liquids & gummies segment is expected to have the highest CAGR during the forecast period

The liquids and gummies segment is anticipated to register the highest growth rate, driven by a fundamental shift in consumer preference towards enjoyable and convenient supplement formats. These delivery systems are particularly appealing to key demographics such as children, seniors, and anyone who has difficulty swallowing traditional pills or capsules. Additionally, the pleasant taste and chewable nature of gummies improve adherence to daily supplement regimens. Manufacturers are capitalizing on this trend by innovating with sugar-free options, natural flavors, and high-potency formulations, making this the most dynamic and rapidly expanding segment in the market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. This leadership position is attributed to several key factors, including high consumer health awareness, strong disposable income, and a well-established retail and e-commerce infrastructure for dietary supplements. The region has a mature consumer base that is well-informed about the gut-health-immune-system connection, driving consistent demand. Moreover, the presence of major market players, aggressive marketing strategies, and a robust regulatory framework that inspires consumer confidence collectively solidify North America's dominant position in the market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This explosive growth is fueled by a rapidly expanding middle class with increasing disposable income, rising health consciousness, and growing awareness of preventive healthcare. Urbanization and the influence of Western health trends are making consumers more receptive to dietary supplements. Furthermore, the vast population base in countries like China and India presents an immense, yet under-penetrated, market opportunity. Local manufacturers are also actively developing affordable products tailored to regional preferences, creating a highly dynamic and fast-growing market landscape.

Key players in the market

Some of the key players in Gut Health and Microbiome Supplement Market include Nestle Health Science, Bayer AG, Church & Dwight Co., Inc., NOW Health Group, Danone S.A., Procter & Gamble Co., BioGaia AB, Dr. Willmar Schwabe GmbH & Co. KG, Amway Corporation, Reckitt Benckiser Group plc, DSM-Firmenich, Yakult Honsha Co., Ltd., Seed Health, Inc., Pendulum Therapeutics, BIOHM Health, Seres Therapeutics, Inc., Ferring B.V., BiomeBank, International Flavors & Fragrances Inc. (IFF), and OptiBiotix Health Plc.

Key Developments:

In June 2025, Danone announces the acquisition of The Akkermansia Company (TAC), a Belgian company with nearly 20 years of history and science, specializing in biotics. Expanding deeper into gut health is a key facet of Danone's Renew strategy, as it doubles down on science and innovation, and as consumer interest in healthy products continues to rise.

In April 2025, DSM-Firmenich launched its Healthy Longevity innovation platform at Vitafoods Europe 2025, focusing on gut health and healthy aging.

In March 2024, Garden of Life, a Nestle Health Science brand, launched Non-GMO and USDA Organic Certified probiotics within its sports nutrition portfolio promoting digestive health.

Product Types Covered:

• Probiotics
• Prebiotics
• Synbiotics
• Postbiotics
• Enzymes
• Other Product Types

Ingredients Covered:

• Bacteria
• Yeast
• Fibers

Formulations Covered:

• Capsules & Tablets
• Powder & Sachets
• Liquids & Gummies

Distribution Channels Covered:

• Hypermarkets/Supermarkets
• Pharmacies & Drug Stores
• Online Retail/E-commerce
• Specialty Stores

Applications Covered:

• Digestive Health
• Immune Support
• Weight Management
• Mental & Cognitive Health
• Other Applications

End Users Covered:

• Adults
• Children
• Elderly

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Gut Health and Microbiome Supplement Market, By Product Type

• 5.1 Introduction
• 5.2 Probiotics
• 5.3 Prebiotics
• 5.4 Synbiotics
• 5.5 Postbiotics
• 5.6 Enzymes
• 5.7 Other Product Types

6 Global Gut Health and Microbiome Supplement Market, By Ingredient

• 6.1 Introduction
• 6.2 Bacteria
• 6.3 Yeast
• 6.4 Fibers

7 Global Gut Health and Microbiome Supplement Market, By Formulation

• 7.1 Introduction
• 7.2 Capsules & Tablets
• 7.3 Powder & Sachets
• 7.4 Liquids & Gummies

8 Global Gut Health and Microbiome Supplement Market, By Distribution Channel

• 8.1 Introduction
• 8.2 Hypermarkets/Supermarkets
• 8.3 Pharmacies & Drug Stores
• 8.4 Online Retail/E-commerce
• 8.5 Specialty Stores

9 Global Gut Health and Microbiome Supplement Market, By Application

• 9.1 Introduction
• 9.2 Digestive Health
• 9.3 Immune Support
• 9.4 Weight Management
• 9.5 Mental & Cognitive Health
• 9.6 Other Applications

10 Global Gut Health and Microbiome Supplement Market, By End User

• 10.1 Introduction
• 10.2 Adults
• 10.3 Children
• 10.4 Elderly

11 Global Gut Health and Microbiome Supplement Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Nestle Health Science
• 13.2 Bayer AG
• 13.3 Church & Dwight Co., Inc.
• 13.4 NOW Health Group
• 13.5 Danone S.A.
• 13.6 Procter & Gamble Co.
• 13.7 BioGaia AB
• 13.8 Dr. Willmar Schwabe GmbH & Co. KG
• 13.9 Amway Corporation
• 13.10 Reckitt Benckiser Group plc
• 13.11 DSM-Firmenich
• 13.12 Yakult Honsha Co., Ltd.
• 13.13 Seed Health, Inc.
• 13.14 Pendulum Therapeutics
• 13.15 BIOHM Health
• 13.16 Seres Therapeutics, Inc.
• 13.17 Ferring B.V.
• 13.18 BiomeBank
• 13.19 International Flavors & Fragrances Inc. (IFF)
• 13.20 OptiBiotix Health Plc